Steffen Steurer

1.5k total citations
9 papers, 279 citations indexed

About

Steffen Steurer is a scholar working on Organic Chemistry, Molecular Biology and Hematology. According to data from OpenAlex, Steffen Steurer has authored 9 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 6 papers in Molecular Biology and 2 papers in Hematology. Recurrent topics in Steffen Steurer's work include Asymmetric Synthesis and Catalysis (5 papers), Synthetic Organic Chemistry Methods (3 papers) and Chemical Synthesis and Analysis (2 papers). Steffen Steurer is often cited by papers focused on Asymmetric Synthesis and Catalysis (5 papers), Synthetic Organic Chemistry Methods (3 papers) and Chemical Synthesis and Analysis (2 papers). Steffen Steurer collaborates with scholars based in Germany, Austria and United States. Steffen Steurer's co-authors include Joachim Podlech, Gerd Bader, Jessica L. Minder, Junwei Shi, Yutaka Suzuki, Mark Pearson, Laetitia J. Martin, Anja Hohmann, Thomas Gerstberger and Jae‐Seok Roe and has published in prestigious journals such as Cancer Research, Nature Chemical Biology and Organic Letters.

In The Last Decade

Steffen Steurer

9 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steffen Steurer Germany 7 222 90 52 52 43 9 279
Matthew Lindon United Kingdom 9 292 1.3× 80 0.9× 58 1.1× 107 2.1× 9 0.2× 11 393
Maryanna E. Lanning United States 13 388 1.7× 199 2.2× 77 1.5× 67 1.3× 23 0.5× 15 472
Stephanos Ioannidis United States 13 181 0.8× 125 1.4× 123 2.4× 42 0.8× 29 0.7× 20 370
Pondy Murugappan Ramanujulu Singapore 10 279 1.3× 103 1.1× 112 2.2× 20 0.4× 17 0.4× 10 394
Hugh Zhu China 11 333 1.5× 274 3.0× 42 0.8× 27 0.5× 39 0.9× 16 551
Harish Nagaraj Singapore 7 190 0.9× 103 1.1× 134 2.6× 74 1.4× 27 0.6× 8 365
Mairead Young United States 8 239 1.1× 148 1.6× 86 1.7× 79 1.5× 10 0.2× 8 399
Aaron Kunzer United States 8 302 1.4× 195 2.2× 74 1.4× 18 0.3× 34 0.8× 11 472
Audrey M. Davies United States 8 116 0.5× 74 0.8× 99 1.9× 32 0.6× 23 0.5× 10 257
Tracy J. Jenkins United States 7 113 0.5× 167 1.9× 24 0.5× 30 0.6× 24 0.6× 7 301

Countries citing papers authored by Steffen Steurer

Since Specialization
Citations

This map shows the geographic impact of Steffen Steurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Steurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Steurer more than expected).

Fields of papers citing papers by Steffen Steurer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Steurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Steurer. The network helps show where Steffen Steurer may publish in the future.

Co-authorship network of co-authors of Steffen Steurer

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Steurer. A scholar is included among the top collaborators of Steffen Steurer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Steurer. Steffen Steurer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Waizenegger, Irene C., Anke Baum, Steffen Steurer, et al.. (2016). A Novel RAF Kinase Inhibitor with DFG-Out–Binding Mode: High Efficacy in BRAF-Mutant Tumor Xenograft Models in the Absence of Normal Tissue Hyperproliferation. Molecular Cancer Therapeutics. 15(3). 354–365. 68 indexed citations
2.
Hohmann, Anja, Laetitia J. Martin, Jessica L. Minder, et al.. (2016). Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition. Nature Chemical Biology. 12(9). 672–679. 134 indexed citations
3.
Hohmann, Anja, Laetitia J. Martin, Jessica L. Minder, et al.. (2016). Abstract LB-206: A bromodomain-swap allele demonstrates that on-target chemical inhibition of BRD9 limits the proliferation of acute myeloid leukemia cells. Cancer Research. 76(14_Supplement). LB–206. 3 indexed citations
4.
Steurer, Steffen & Joachim Podlech. (2002). Indium-Induced Addition of Bromomethylacrylates to Phthaloyl-Protected Amino Aldehydes. Synthesis. 2002(7). 945–950. 4 indexed citations
5.
Steurer, Steffen & Joachim Podlech. (2002). Synthesis of Highly Functionalized Amino Acid and Hydroxy Acid Derivatives from γ‐Aminoalkyl‐Substituted α‐Methylene‐γ‐butyrolactones. European Journal of Organic Chemistry. 2002(5). 899–916. 12 indexed citations
6.
Steurer, Steffen & Joachim Podlech. (2001). Indium-Catalyzed Barbier-Reactions of Amino Aldehydes. Advanced Synthesis & Catalysis. 343(3). 251–254. 15 indexed citations
7.
Steurer, Steffen & Joachim Podlech. (1999). 1,4-Additions to γ-Aminoalkyl-Substituted α-Methylene γ-Butyrolactones:  Synthesis of Highly Functionalized Amino Acid Derivatives. Organic Letters. 1(3). 481–484. 7 indexed citations
8.
Steurer, Steffen & Joachim Podlech. (1999). Aminoalkyl-Substituted α-Methylene-γ-butyrolactones from α-Amino Acids Using an Indium-Mediated Barbier Allyl Addition. European Journal of Organic Chemistry. 1999(7). 1551–1560. 20 indexed citations
9.
Podlech, Joachim & Steffen Steurer. (1999). A Chiral, Oxidatively Cleavable Auxiliary in β-Lactam Synthesis - Double Diastereocontrol with p-Methoxyphenethyl-Substituted Imines. Synthesis. 1999(4). 650–654. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew Lindon Breakdown of academic impact, for papers by Maryanna E. Lanning Breakdown of academic impact, for papers by Stephanos Ioannidis Breakdown of academic impact, for papers by Pondy Murugappan Ramanujulu Breakdown of academic impact, for papers by Hugh Zhu Breakdown of academic impact, for papers by Harish Nagaraj Breakdown of academic impact, for papers by Mairead Young Breakdown of academic impact, for papers by Aaron Kunzer Breakdown of academic impact, for papers by Audrey M. Davies Breakdown of academic impact, for papers by Tracy J. Jenkins
Rankless by CCL
2026